Finance

Beta
Lists
ELIC:STO
Elicera Therapeutics AB
SEK 2,70
0,00%
(0,00) 1D
18 Jun., 17:29:39 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ELIC...
Mkt. cap
196,20 m
Avg. vol.
602,96 k
Volume
0,00
52-wk high
SEK 8,21
52-wk low
SEK 2,26
EPS
-SEK 0,29
Shares outstanding
48,54 m
No. of employees
3
Mkt. cap
196,20 m
Avg. vol.
602,96 k
Volume
0,00
52-wk high
SEK 8,21
52-wk low
SEK 2,26
EPS
-SEK 0,29
Shares outstanding
48,54 m
No. of employees
3
News stories
From sources across the web
About Elicera Therapeutics AB
CEO-
Employees3
Founded2014
Headquarters-
Sector-
Websiteelicera.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
2,70 m
7,91 m
30,00 k
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,59 m
7,76 m
7,16 m
5,12 m
Operating expense
5,59 m
7,76 m
7,16 m
5,12 m
Total operating expenses
5,59 m
7,76 m
7,16 m
5,12 m
Operating income
-2,89 m
146,69 k
-7,13 m
-5,12 m
Other non operating income
-
1,32 k
-
-
EBT including unusual items
-2,73 m
304,15 k
-6,97 m
-5,06 m
EBT excluding unusual items
-2,73 m
304,15 k
-6,97 m
-5,06 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,73 m
304,15 k
-6,97 m
-5,06 m
Net profit margin
-101,33%
3,85%
-23 219,94%
-
Earnings per share
-
-
-
-
Interest and investment income
164,29 k
156,14 k
169,41 k
61,50 k
Interest expense
-4,02 k
-
-5,07 k
-4,78 k
Net interest expenses
160,27 k
156,14 k
164,34 k
56,72 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,89 m
149,63 k
-7,13 m
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer